Literature DB >> 7387219

Hepatotoxicity associated with use of D-penicillamine in rheumatoid arthritis.

J Rosenbaum, W A Katz, H R Schumacher.   

Abstract

Two patients with rheumatoid arthritis developed evidence of hepatotoxicity while receiving D-penicillamine. Both recovered after withdrawal of the drug. These cases and a review of the literature suggested that hepatotoxicity, though rare, should be added to the list of adverse reactions to D-penicillamine.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7387219      PMCID： PMC1000500          DOI： 10.1136/ard.39.2.152

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  8 in total

1.  Letter: Aspirin hepatotoxicity.

Authors:  E Garber; R M Craig; R M Bahu
Journal:  Ann Intern Med       Date:  1975-04       Impact factor: 25.391

2.  [Intrahepatic cholestasis following treatment with D-penicillamine and indomethacin].

Authors:  H Siegmund
Journal:  Med Welt       Date:  1976-01-23

3.  [Allergic-toxic liver damage due to D-penicillamine].

Authors:  R Rau; S Weber; A Böni
Journal:  Schweiz Med Wochenschr       Date:  1972-08-26

4.  Toxic hepatitis after therapeutic doses of benorylate and D-penicillamine.

Authors:  M Sacher; H Thaler
Journal:  Lancet       Date:  1977-02-26       Impact factor: 79.321

5.  [Severe side-effects of treatment with D-penicillamine (author's transl)].

Authors:  H H Hennemann; H Hubertus; W G Stocker
Journal:  Dtsch Med Wochenschr       Date:  1975-08-08       Impact factor: 0.628

6.  Cholestatic jaundice caused by D-penicillamine.

Authors:  D Barzilai; G Dickstein; R Enat; H Bassan; C Lichtig; B Gellei
Journal:  Ann Rheum Dis       Date:  1978-02       Impact factor: 19.103

7.  Toxicity of D-penicillamine in rheumatoid arthritis. A report of 63 patients including two with aplastic anemia and one with the nephrotic syndrome.

Authors:  A S Weiss; J A Markenson; M S Weiss; W H Kammerer
Journal:  Am J Med       Date:  1978-01       Impact factor: 4.965
  8 in total
  5 in total

1.  Azathioprine induced hepatic veno-occlusive disease in rheumatoid arthritis.

Authors:  D E Lemley; L M DeLacy; L B Seeff; K G Ishak; D J Nashel
Journal:  Ann Rheum Dis       Date:  1989-04       Impact factor: 19.103

Review 2.  Clinical associations between arthritis and liver disease.

Authors:  P R Mills; R D Sturrock
Journal:  Ann Rheum Dis       Date:  1982-06       Impact factor: 19.103

3.  D-penicillamine-induced granulomatous hepatitis in brown Norway rats.

Authors:  Imir G Metushi; Xu Zhu; Jack Uetrecht
Journal:  Mol Cell Biochem       Date:  2014-04-27       Impact factor: 3.396

4.  Raised serum alkaline phosphatase and aspartate transaminase levels in two rheumatoid patients treated with sulphasalazine.

Authors:  M Farr; D P Symmons; P A Bacon
Journal:  Ann Rheum Dis       Date:  1985-11       Impact factor: 19.103

5.  Fatal aplastic anaemia and liver toxicity caused by D-penicillamine treatment of rheumatoid arthritis.

Authors:  B Fishel; M Tishler; D Caspi; M Yaron
Journal:  Ann Rheum Dis       Date:  1989-07       Impact factor: 19.103
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.